pAuroraA-GFP-AURKA-mCherry
(Plasmid
#99878)
-
PurposeExpression of GFP-AURKA-mCherry in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 99878 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepEGFP-C1
-
Backbone manufacturerClontech
-
Modifications to backboneCMV promoter was substituted by the AURKA minimal promoter sequence (CTTCCGG) into the AseI/BspEI restriction sites
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAURKA
-
SpeciesH. sapiens (human)
-
Entrez GeneAURKA (a.k.a. AIK, ARK1, AURA, BTAK, PPP1R47, STK15, STK6, STK7)
- Promoter AURKA minimal
-
Tags
/ Fusion Proteins
- GFP (N terminal on backbone)
- mCherry (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Unknown (unknown if destroyed)
- 3′ cloning site Unknown (unknown if destroyed)
- 5′ sequencing primer EGFP-C (Common Sequencing Primers)
Resource Information
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAuroraA-GFP-AURKA-mCherry was a gift from Marc Tramier (Addgene plasmid # 99878 ; http://n2t.net/addgene:99878 ; RRID:Addgene_99878) -
For your References section:
A FRET biosensor reveals spatiotemporal activation and functions of aurora kinase A in living cells. Bertolin G, Sizaire F, Herbomel G, Reboutier D, Prigent C, Tramier M. Nat Commun. 2016 Sep 14;7:12674. doi: 10.1038/ncomms12674. 10.1038/ncomms12674 PubMed 27624869